LRP-666

N/A

Report date: 2024/04/30 13:52:25

Base Information

Drug NameLRP-666
Drug Alias Namedelta-9-tetrahydrocannabinol or THC sulphate (THCS)LRP-666
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid receptor modulators
TargetsCannabinoid receptor
Therapy Area/IndicationsInflammationNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLondon Pharmaceuticals and Research Corp
China Registration ClassN/A

Develop Information

Active CompaniesLondon Pharmaceuticals and Research Corp
Inactive CompaniesN/A
Active IndicationsInflammationNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A